KEYNOTE-365

12 Mar, 2021

Dr. Rajesh Bollam

Image

🔶KEYNOTE-365 @ASCO #GU21 by Dr. Leonard Joseph Appleman @UPMCHillmanCC

🔶Pembrolizumab+docetaxel in #mCRPC s/p abi/enza, n=104

PSA response (≥50%⬇️): 34%

ORR: 23.1%

rPFS: 8.5 mos

OS: 20.2 mos

👉KN-921, doce vs doce/pembro underway!

#DrRajeshBollam #HematoOncologist #cancerdoctor #oncologist #Cancer #cancerawareness

Add a comment